Cell & Gene Therapy Supply Chain Software Market Expected to Grow at a 13.9% CAGR from 2024-2031 | Latest Report by InsightAce Analytic [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
CryoPort, Inc. (CYRX)
NASDAQ:AMEX Investor Relations:
ir.cryoport.com
Company Research
Source: Yahoo! Finance
Cell & Gene Therapy Supply Chain Software Market Size, Share & Trends Analysis Report By Business Type (Transport, Warehouse, Distribution, Value-Added Services), Mode Of Operation (Storage, Roadways, Seaways), And End Use, Region, Market Outlook And Industry Analysis 2031". The Cell & Gene Therapy Supply Chain Software Market is poised for significant growth, projected to surpass USD 668.4 Mn by 2031 , with a promising CAGR of 13.9% during the forecast period. Enhanced therapies, including cell and gene therapy products, have reformed healthcare practices. The prevalence of such therapeutic options has led to an uprise shift in modern medicine's development, production, and consumption. Moreover, such therapies have established healthcare providers to treat several rare clinical conditions. Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/2520 Supply chain software in this sector encompasses solutions for inventory management, logistics, temper
Show less
Read more
Impact Snapshot
Event Time:
CYRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYRX alerts
High impacting CryoPort, Inc. news events
Weekly update
A roundup of the hottest topics
CYRX
News
- The Schall Law Firm Is Examining Allegations Against Cryoport Inc And Encourages Its Shareholders To Establish CommunicationAccesswire
- The Schall Law Firm Is Investigating Claims Against Cryoport Inc And Urges Its Shareholders To Make ContactAccesswire
- Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies [Yahoo! Finance]Yahoo! Finance
- Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene TherapiesPR Newswire
- The Schall Law Firm Is Probing Allegations Against Cryoport Inc And Encourages Its Investors To Reach OutAccesswire
CYRX
Earnings
- 5/7/24 - Miss
CYRX
Sec Filings
- 6/14/24 - Form S-8
- 5/30/24 - Form SD
- 5/22/24 - Form 8-K
- CYRX's page on the SEC website